sever
acut
respiratori
syndrom
coronaviru
middl
east
respiratori
syndrom
coronaviru
caus
sever
pneumonia
human
current
vaccin
therapeut
licens
use
coronavirus
spike
protein
coronavirus
bind
cellular
receptor
mediat
membran
fusion
cell
antibodi
protein
block
viru
bind
fusion
neutral
viru
thu
protein
candid
vaccin
target
block
coronaviru
howev
anim
studi
suggest
insuffici
protect
immun
may
induc
eosinophil
immunopatholog
lung
enhanc
lung
eosinophil
immunopatholog
becam
problem
respiratori
syncyti
viru
vaccin
combin
alum
adjuv
inject
intramuscularli
children
immun
outcom
result
increas
mortal
due
enhanc
respiratori
diseas
upon
subsequ
rsv
infect
immun
children
increas
mortal
thought
due
skew
immun
respons
toward
respons
enhanc
eosinophil
infiltr
addit
product
nonprotect
antibodi
respons
vaccin
may
due
poor
receptor
tlr
previou
studi
show
vaccin
induc
strong
immun
respons
tlr
agonist
could
limit
develop
lung
eosinophil
studi
produc
recombin
tag
protein
contain
ectodomain
protein
via
baculoviru
express
system
evalu
efficaci
vaccin
potenti
induc
lung
eosinophil
immunopatholog
murin
sar
recombin
antibodi
protect
infect
howev
lung
eosinophil
immunopatholog
observ
lung
immun
mice
sar
infect
thu
even
protein
vaccin
adjuv
requir
prevent
lung
eosinophil
immunopatholog
follow
infect
vaccin
expect
improv
vaccin
efficaci
immun
strategi
target
deliveri
promot
immun
gold
nanoparticl
aunp
becom
choic
immunotherapi
applic
physicochem
properti
prevent
antibodi
product
platform
furthermor
vitro
vivo
studi
reveal
variou
immun
cell
includ
macrophag
dendrit
cell
lymphocyt
stimul
aunp
lead
product
cytokin
ie
cytokin
thu
studi
evalu
two
kind
vaccin
adjuv
includ
aunp
expect
function
antigen
carrier
adjuv
immun
tlr
agonist
previous
shown
function
adjuv
increas
efficaci
ultraviolet
uv
experi
involv
recombin
dna
pathogen
approv
committe
experi
use
recombin
dna
pathogen
nation
institut
infecti
diseas
tokyo
japan
anim
studi
carri
strict
accord
guidelin
proper
conduct
anim
experi
scienc
council
japan
anim
experi
conduct
strict
complianc
anim
husbandri
welfar
regul
anim
hous
japan
health
scienc
facil
anim
experi
approv
committe
experiment
anim
nation
institut
infecti
diseas
japan
approv
experiment
anim
handl
biosafeti
level
anim
facil
accord
guidelin
committe
approv
cell
high
deriv
trichoplusia
maintain
medium
shima
laboratori
tokyo
japan
supplement
fetal
bovin
serum
fb
japan
tokyo
japan
kanamycin
thermo
fisher
scientif
waltham
tryptos
phosphat
broth
thermo
fisher
scientif
insect
cell
deriv
spodoptera
kindli
provid
dr
yoshiharu
matsuura
osaka
univers
osaka
japan
maintain
sfm
thermo
fisher
scientif
supplement
fb
kanamycin
thermo
fisher
scientif
incub
vero
cell
deriv
african
green
monkey
kidney
atcc
american
type
cell
collect
manassa
va
cultur
eagl
minimum
essenti
medium
mem
japan
contain
fb
japan
iuml
penicillin
g
streptomycin
thermo
fisher
scientif
stock
frankfurt
isol
propag
twice
titrat
vero
cell
prior
cryopreserv
describ
viral
infect
titer
express
tissu
cultur
infecti
dose
ml
vero
cell
calcul
accord
method
work
infecti
perform
biosafeti
level
condit
recombin
coronaviru
protein
prepar
use
baculoviru
express
system
describ
sequenc
coronaviru
protein
obtain
frankfurt
strain
ncbi
access
nucleotid
sequenc
encod
amino
acid
protein
ectodomain
tag
clone
transfer
vector
kindli
provid
dr
matsuura
osaka
predict
molecular
weight
recombin
protein
kda
recombin
baculoviru
produc
insect
cell
use
bd
baculo
gold
linear
baculoviru
dna
bd
bioscienc
franklin
lake
nj
unifector
reagent
intern
santa
clara
ca
accord
manufactur
instruct
next
insect
cell
infect
recombin
baculoviru
produc
recombin
protein
four
day
infect
recombin
protein
purifi
cultur
supernat
via
affin
chromatographi
use
plu
system
primeview
softwar
ge
healthcar
japan
tokyo
japan
collect
use
histrap
excel
column
ge
healthcar
japan
purifi
protein
heat
sampl
buffer
solut
wako
tokyo
japan
min
size
fraction
via
sodium
dodecyl
gel
electrophoresi
polyacrylamid
gel
thermo
fisher
scientif
protein
stain
coomassi
brilliant
blue
stain
solut
hercul
ca
western
blot
protein
fraction
via
transfer
polyvinyliden
difluorid
membran
merck
millipor
burlington
membran
incub
block
reagent
toyobo
osaka
japan
hr
room
temperatur
rt
improv
signal
rabbit
antibodi
sar
glycoprotein
abcam
cambridg
uk
mous
horseradish
peroxidas
hrp
antibodi
oghi
mbl
life
scienc
nagoya
japan
use
primari
antibodi
incub
primari
antibodi
hr
rt
membran
treat
secondari
antibodi
abcam
hr
rt
wash
tween
salin
wako
protein
detect
use
immobilon
western
chemiluminesc
hrp
substrat
merck
millipor
imag
captur
la
luminesc
imag
analyz
fujifilm
tokyo
japan
concentr
purifi
protein
measur
use
pierc
bca
protein
assay
kit
thermo
fisher
scientif
nano
drop
microvolum
spectrophotomet
thermo
fisher
scientif
bi
phenylphosphin
dihydr
dipotassium
salt
bspp
coat
gold
nanoparticl
carri
accord
previou
literatur
aunp
prepar
commerci
gold
colloid
diamet
nm
bbi
solut
south
wale
uk
nm
bbi
solut
bspp
mm
nm
aunp
mm
nm
aunp
merck
millipor
mix
gold
colloid
particl
concentr
nm
overnight
room
temperatur
shake
centrifug
mixtur
two
time
min
remov
excess
bspp
pellet
resuspend
distil
water
concentr
nm
aunp
pass
filter
merck
millipor
purifi
recombin
protein
ad
aunp
mixtur
incub
room
temperatur
hr
adsorpt
dynam
light
scatter
dl
measur
use
hydrodynam
diamet
otsuka
electron
osaka
japan
measur
perform
dispos
uv
cuvett
violamo
one
osaka
japan
use
sampl
volum
anim
immun
mixtur
ad
salin
distil
water
pb
maintain
final
concentr
protein
aunp
anim
immun
use
mixtur
without
purif
ie
mixtur
centrifug
wash
pb
adsorpt
protein
fmol
nm
aunp
pb
refer
saunp
protein
aunp
quantifi
saunp
solut
concentr
via
centrifug
min
rt
supernat
remov
wash
pb
twice
pellet
resuspend
pb
sampl
buffer
ad
extract
protein
surfac
aunp
heat
min
denatur
protein
solut
centrifug
min
rt
complet
precipit
aunp
bind
supernat
subject
protein
sampl
known
concentr
protein
adjust
nglane
subject
follow
western
blot
analyz
via
western
blot
antibodi
immunoreact
protein
detect
quantifi
via
densitometri
use
luminesc
imag
analyz
fujifilm
purifi
protein
aunp
saunp
pb
observ
transmiss
electron
microscopi
sampl
cu
grid
veco
grid
nisshin
em
tokyo
japan
stain
phosphotungst
acid
wako
data
collect
use
transmiss
electron
microscop
hitachi
tokyo
japan
oper
electron
beam
kv
magnif
confirm
immunogen
purifi
recombin
protein
balbc
mice
femal
week
old
japan
slc
shizuoka
japan
n
total
immun
subcutan
twice
week
interv
dose
protein
pb
evalu
final
concentr
aunp
protein
anim
immun
protein
ad
nm
solut
aunp
final
concentr
protein
aunp
anim
immun
follow
experi
protein
nm
solut
aunp
prepar
dilut
immun
dose
per
mous
follow
protein
fmol
aunp
protein
fmol
aunp
protein
fmol
aunp
experi
protein
fmol
aunp
anim
experi
conduct
subcutan
immun
balbc
mice
femal
n
total
mice
approxim
week
interv
evalu
optimum
aunp
diamet
anim
immun
nm
nm
aunp
prepar
purifi
protein
fmol
aunp
use
immun
balbc
mice
week
old
femal
n
total
subcutan
immun
twice
week
interv
assess
effect
adjuv
purifi
protein
formul
aunp
tlr
agonist
per
dose
tlr
agonist
consist
lipopolysaccharid
lp
st
loui
mo
poli
c
invitrogen
san
diego
ca
poli
u
invitrogen
pb
per
femal
balbc
mice
femal
japan
slc
n
total
immun
subcutan
twice
week
interv
saunp
stlr
protein
pb
control
mice
inject
subcutan
pb
without
fmol
aunp
twice
week
interv
two
week
immun
serum
sampl
collect
mice
measur
antibodi
respons
approxim
week
second
immun
mice
anesthet
via
intraperiton
inject
mixtur
mg
ketamin
daiichi
sankyo
compani
tokyo
japan
mg
xylazin
g
bodi
weight
byer
japan
osaka
japan
mice
inocul
intranas
infect
mice
observ
clinic
sign
infect
bodi
weight
measur
daili
day
n
mice
total
immun
mice
analyz
viral
replic
cytokin
express
patholog
anim
kill
variou
time
point
inocul
n
mice
per
group
total
viral
inocul
perform
anesthesia
effort
made
minim
potenti
pain
distress
inocul
anim
monitor
day
studi
human
endpoint
defin
appear
clinic
diagnost
sign
respiratori
stress
includ
respiratori
distress
weight
loss
anim
euthan
anesthesia
overdos
isofluran
sever
diseas
symptom
weight
loss
observ
lung
tissu
homogen
wtvol
prepar
sampl
clarifi
via
centrifug
min
supernat
inocul
onto
vero
cell
cultur
viru
titrat
assess
specif
igg
produc
immun
mice
recombin
protein
igg
igg
use
immunosorb
assay
elisa
antigen
antigen
use
convent
elisa
describ
briefli
assay
plate
corn
inc
corn
ny
coat
ng
purifi
protein
coat
buffer
ph
thermo
fischer
scientif
plate
wash
three
time
pb
contain
tween
blockac
ds
pharma
biomed
kk
osaka
japan
ad
well
plate
incub
hr
serum
sampl
serial
dilut
blockac
igg
elisa
igg
elisa
dilut
sampl
ad
plate
incub
hr
three
wash
well
incub
igg
thermo
fischer
scientif
antibodi
dilut
blockac
three
wash
abt
substrat
roch
basel
switzerland
ad
well
plate
incub
min
optic
densiti
od
well
measur
nm
use
micropl
reader
model
valu
calcul
mean
od
valu
plu
three
standard
deviat
mean
sd
determin
dilut
use
serum
sampl
preimmun
mice
igg
titer
defin
reciproc
highest
dilut
od
valu
higher
valu
serum
sampl
dilut
rang
sampl
mix
viru
solut
per
well
mixtur
incub
hr
neutral
incub
mixtur
inocul
onto
monolay
cell
cultur
plate
follow
incub
day
cell
examin
cytopath
effect
sera
titer
neutral
antibodi
calcul
reciproc
highest
dilut
cytopath
effect
observ
mice
anesthet
perfus
ml
formalin
wako
lung
harvest
fix
embed
paraffin
section
stain
hematoxylin
eosin
eosinophil
identifi
via
astra
bluevit
new
red
stain
combin
eosinophilmast
cell
stain
cem
stain
kit
db
pleasanton
ca
use
astra
bluevit
new
slide
peribronchiolar
area
five
section
assess
light
microscopi
use
digit
camera
cellsen
softwar
olympu
tokyo
japan
number
eosinophil
count
lung
mous
averag
describ
level
cytokin
chemokin
mous
lung
homogen
wtvol
measur
use
custom
mous
cytokinechemokin
magnet
bead
panel
plate
assay
kit
milliplex
map
kit
merck
millipor
includ
cytokin
chemokin
eotaxin
interferon
gamma
interleukin
alpha
gamma
protein
chemokin
kc
kc
monocyt
chemotact
macrophag
inflammatori
protein
alpha
granulocyt
macrophag
factor
monokin
induc
gamma
interferon
mig
regul
activ
normal
cell
express
secret
rant
tumor
necrosi
factor
alpha
assay
sampl
read
luminex
instrument
xponent
softwar
merck
millipor
describ
manufactur
measur
level
type
ifn
messeng
rna
mrna
express
rna
extract
wv
lung
homogen
mice
use
rneasi
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
level
mrna
encod
examin
via
revers
chain
reaction
use
abi
prism
fast
pcr
system
appli
biosystem
foster
citi
ca
taqman
probe
primer
follow
forward
caactctactagactcattctgcaat
revers
agaggaggttcctgcatcaca
probe
acctccatcagcagctcaatgacctcaaa
forward
gctcctggagcagctgaatg
revers
tccgtcatctccatagggatct
probe
tcaacctcacctacagggcggacttc
forward
acggccaggtcatcactattg
revers
caagaaggaaggctggaaaaga
probe
caacgagcggttccgatgccc
reaction
condit
describ
briefli
reaction
mixtur
incub
min
follow
incub
min
thermal
cycl
consist
cycl
denatur
anneal
extens
express
gene
normal
data
express
mean
standard
error
mean
statist
analys
perform
use
graph
pad
prism
softwar
graphpad
softwar
la
jolla
ca
bodi
weight
curv
viru
titer
eosinophil
count
multiplex
assay
result
analyz
use
analysi
varianc
anova
tukey
multipl
comparison
test
use
compar
result
group
result
antibodi
titer
assay
analyz
use
nonparametr
test
dunn
multipl
comparison
test
follow
test
valu
p
consid
statist
signific
recombin
tag
protein
includ
ectodomain
protein
gener
use
baculoviru
express
system
protein
contain
larg
ectodomain
short
endodomain
bridg
hydrophob
transmembran
domain
figur
ectodomain
protein
extens
glycosyl
glycosyl
report
import
interact
receptor
surfac
host
addit
avoid
insolubl
protein
express
caus
numer
hydrophob
amino
acid
transmembran
domain
includ
endodomain
remov
recombin
spike
protein
figur
higher
express
obtain
construct
encod
recombin
protein
contain
carboxyl
terminu
compar
obtain
construct
purif
recombin
tag
protein
cultur
supernat
via
gel
filtrat
chromatographi
ident
recombin
protein
expect
molecular
weight
kda
confirm
via
western
blot
figur
confirm
immunogen
recombin
protein
purifi
protein
use
immun
balbc
mice
group
mice
immun
differ
amount
recombin
protein
per
immun
challeng
two
week
second
immun
protein
igg
product
assess
immun
mice
figur
approxim
week
second
immun
mice
week
old
time
challeng
intranas
inocul
nonimmun
anim
show
bodi
weight
reduct
approxim
compar
initi
bodi
weight
four
six
mice
moribund
euthan
within
day
postinocul
dpi
figur
two
anim
fulli
recov
dpi
hand
immun
anim
show
bodi
weight
loss
within
dpi
anim
immun
group
recov
dpi
howev
three
seven
mice
immun
group
three
six
immun
group
recov
moribund
anim
surviv
recov
fulli
dpi
summari
mice
surviv
infect
lethal
dose
mice
immun
group
figur
three
seven
mice
immun
group
three
six
group
moribund
euthan
within
dpi
anim
kill
meet
criteria
euthanasia
addit
found
eosinophil
infiltr
around
bronchiol
lung
almost
immun
mice
day
challeng
infect
figur
b
previou
work
immun
model
specul
insuffici
immun
recombin
protein
induc
eosinophil
infiltr
lung
upon
infect
balbc
mous
therefor
next
investig
efficaci
vaccin
adjuv
examin
effect
two
type
vaccin
adjuv
aunp
use
antigen
carrier
adjuv
subunit
vaccin
group
tlr
agonist
group
recombin
protein
use
immun
conjug
protein
aunp
confirm
detect
chang
diamet
aunp
bspp
coat
protein
bind
dl
tabl
optim
aunp
concentr
determin
measur
ig
g
respons
use
elisa
antigen
second
immun
stabl
result
obtain
protein
fmol
aunp
use
immun
balbc
mice
figur
b
also
evalu
influenc
diamet
aunp
anim
immun
effect
size
shape
aunp
immunolog
respons
previous
evalu
studi
west
nile
viru
envelop
protein
protein
nm
spheric
aunp
induc
suffici
level
antibodi
wnv
particl
around
nm
diamet
evalu
nm
spheric
aunp
modifi
particl
rang
nm
anim
experi
reveal
differ
igg
respons
spheric
aunp
diamet
nm
use
immun
figur
use
protein
fmol
nm
aunp
follow
experi
amount
protein
aunp
quantifi
via
western
blot
analysi
adsorpt
protein
aunp
figur
calcul
ratio
amount
protein
amount
free
protein
saunp
solut
via
western
blot
imag
captur
use
la
luminoimag
analyz
fujifilm
analyz
use
imagequ
tl
softwar
ge
healthcar
percentag
protein
bound
aunp
five
experi
addit
structur
saunp
examin
transmiss
electron
microscopi
figur
confirm
protein
bind
aunp
presenc
free
protein
solut
next
evalu
efficaci
adjuv
use
mice
immun
anim
week
old
time
challeng
infect
two
week
second
immun
level
igg
measur
immun
group
level
significantli
higher
group
compar
group
figur
also
confirm
seroconvers
mice
use
elisa
antigen
mice
show
significantli
higher
titer
igg
low
mice
figur
similar
result
obtain
neutral
antibodi
analysi
figur
three
week
second
immun
anim
intranas
inocul
n
within
dpi
mice
show
ruffl
fur
bodi
weight
loss
nonimmun
anim
show
bodi
weight
reduct
moribund
within
dpi
n
figur
e
two
mice
die
pulmonari
edema
meet
criteria
euthanasia
mice
recov
within
dpi
howev
four
seven
mice
two
six
mice
moribund
within
dpi
figur
e
four
mice
group
die
pulmonari
edema
meet
criteria
euthanasia
result
clear
saunp
immun
induc
high
level
igg
weak
product
igg
neutral
antibodi
thu
protect
abil
saunp
vaccin
lower
stlr
vaccin
histopatholog
investig
reveal
eosinophil
infiltr
occur
lung
mice
lung
anim
group
dpi
figur
also
investig
histopatholog
mice
pretreat
aunp
eosinophil
infiltr
observ
infect
aunp
figur
b
next
use
mous
lung
homogen
investig
viral
kinet
immun
reaction
day
pi
viru
titer
initi
low
decreas
lung
mice
other
show
approxim
equal
titer
figur
high
level
type
interferon
detect
lung
nonimmun
mice
lower
delay
respons
observ
anim
group
respons
detect
anim
group
figur
also
investig
cytokin
chemokin
respons
lung
figur
level
cytokin
includ
elev
dpi
control
mice
vaccin
mice
show
moder
induct
proinflammatori
cytokin
chemokin
level
kc
elev
control
mice
dpi
level
sever
chemokin
higher
control
mice
dpi
mice
rant
induc
dpi
control
mice
delay
mice
cytokin
product
respons
follow
induct
observ
mice
day
pi
high
product
allerg
cytokin
chemokin
includ
eotaxin
observ
mice
within
dpi
addit
level
higher
mice
control
mice
signific
differ
level
detect
mice
mice
show
higher
level
day
pi
within
dpi
compar
respect
level
immun
group
cytokin
chemokin
respons
moder
absent
mice
overal
group
mice
show
differ
type
immun
respons
lung
earli
phase
infect
mice
show
proinflammatori
respons
earli
phase
infect
mice
show
respons
accompani
allerg
inflamm
cytokin
induct
observ
mice
develop
vaccin
candid
coronaviru
infect
subunit
vaccin
viral
vector
vaccin
dna
vaccin
target
viral
protein
shown
effect
subunit
vaccin
consid
highli
safe
product
use
antigen
compon
without
need
introduc
viral
furthermor
possibl
induc
cellular
humor
immun
respons
neutral
antibodi
antigen
combin
appropri
research
previous
produc
recombin
protein
show
could
use
induc
high
product
neutral
antibodi
howev
lung
eosinophil
immunopatholog
evalu
studi
et
al
report
immun
commerci
recombin
protein
protein
scienc
corp
meriden
ct
produc
insect
cell
without
alum
adjuv
result
lung
eosinophil
immunopatholog
infect
intramuscularli
twice
protein
succeed
avoid
immunopatholog
induc
vaccin
combin
delta
polysaccharid
adjuv
adjuv
induc
respons
suggest
inadequ
respons
caus
lung
eosinophil
also
observ
previous
agraw
et
al
report
inactiv
vaccin
lead
lung
eosinophil
immunopatholog
product
upon
live
viru
challeng
transgen
mice
bear
human
sever
pneumonia
relat
coronavirus
could
induc
patholog
studi
explor
potenti
aunp
use
adjuv
promot
immun
respons
balanc
effect
aunp
stimul
macrophag
dendrit
cell
lymphocyt
induct
proinflammatori
cytokin
ie
cytokin
ie
niikura
et
al
demonstr
west
nile
viru
e
protein
show
high
antigen
mice
induc
inflammatori
cytokin
product
includ
cell
inde
protein
induc
strong
igg
respons
protein
studi
howev
fail
induc
protect
immun
respons
limit
eosinophil
infiltr
viru
challeng
one
explan
failur
induc
protect
immun
respons
could
structur
chang
protein
upon
bind
aunp
adjuv
result
igg
unabl
neutral
aunp
protein
bind
togeth
via
electrostat
interact
form
protein
corona
around
inde
dl
tem
structur
analysi
indic
conjug
protein
aunp
form
protein
corona
consid
result
structur
chang
adsorb
adapt
nanoparticl
surfac
surround
protein
secondari
structur
strongli
affect
surfac
charg
particl
surfac
protein
corona
defin
biolog
ident
particl
attach
cell
surfac
thu
even
small
modif
protein
structur
could
impact
neg
posit
immunogen
work
requir
studi
mechan
test
whether
vaccin
effect
coronaviru
infect
ie
effect
antigen
bind
method
antigen
receptor
bind
site
cytokin
chemokin
analysi
reveal
group
mice
differ
lung
immun
respons
earli
infect
similar
viru
titer
observ
lung
mice
type
ifn
proinflammatori
respons
moder
mice
infect
type
ifn
secret
infect
cell
macrophag
dendrit
cell
counteract
viral
type
ifn
cytokin
chemokin
includ
chemokin
respons
similar
among
mice
howev
respons
higher
mice
cell
may
also
moder
proinflammatori
reaction
anim
group
interestingli
although
mice
show
signific
protect
infect
viru
titer
remain
higher
mice
adult
mous
model
infect
excess
host
innat
immun
respons
contribut
lung
patholog
complex
involv
chang
activ
macrophag
previous
report
treatment
hr
inocul
protect
mice
sever
pulmonari
edema
otherwis
result
death
uninocul
adult
howev
viru
titer
lung
differ
adult
mice
studi
mice
show
respons
day
pi
thu
specul
induct
may
contribut
protect
sar
protein
immun
mice
pb
pretreat
challeng
control
mice
show
slight
chang
bronchi
area
lung
infect
figur
patholog
chang
lung
includ
diffus
alveolar
damag
mainli
seen
alveolar
howev
eosinophil
infiltr
occur
around
middl
size
blood
vessel
bronchi
area
thu
demonstr
bronchi
area
anim
figur
wherea
small
chang
ie
inflammatori
cell
infiltr
around
blood
vessel
edema
observ
bronchi
area
control
mous
histopatholog
find
eosinophil
infiltr
around
bronchiol
day
pi
correl
high
product
allerg
inflamm
cytokin
eotaxin
mice
find
suggest
amount
antibodi
gener
suffici
orchestr
immun
respons
includ
innat
immun
respons
infect
studi
aunp
show
dose
depend
elicit
immun
respons
weight
poli
c
conjug
gold
nanorod
adjuv
intranas
hemagglutinin
ha
influenza
vaccin
low
dose
aunp
ie
fmol
effect
reduc
viru
replic
nasal
wash
higher
dose
gold
nanorod
ie
fmol
hand
mottram
et
al
show
nanoparticl
size
polystyren
bead
carri
whole
ovalbumin
influenc
immun
reaction
nm
bead
use
vaccin
mice
high
induct
observ
wherea
nm
bead
induc
although
evalu
detail
influenc
amount
size
aunp
amount
size
aunp
care
consid
nanoparticl
vaccin
platform
use
develop
coronaviru
vaccin
studi
express
protein
via
recombin
baculoviru
system
purif
recombin
protein
effect
express
construct
contain
protein
carboxyl
terminu
construct
use
purif
conduct
via
trap
purif
use
affin
chromatographi
minim
protein
loss
second
immun
purifi
recombin
protein
high
igg
level
igg
detect
murin
sera
protect
infect
vivo
subcutan
twice
protein
purifi
protein
show
high
immunogen
balbc
mice
prevent
eosinophil
infiltr
mice
differ
age
use
studi
young
adult
mice
femal
use
confirm
immunogen
recombin
protein
saunp
adult
mice
week
old
challeng
week
old
use
challeng
experi
signific
differ
level
igg
titer
mice
immun
saunp
figur
specul
differ
could
due
differ
age
mice
employ
experi
gener
young
adult
around
week
old
mice
show
robust
immun
respons
old
mice
robust
immun
respons
decreas
addit
interv
first
immun
sera
collect
differ
conduct
minimum
dose
immun
adult
balbc
mice
protein
subcutan
twice
protein
total
tlr
protein
induc
suffici
high
express
neutral
antibodi
prevent
eosinophil
infiltr
infect
induct
rant
mig
type
ifn
express
detect
lung
mice
suffici
antivir
antibodi
interestingli
mice
show
high
level
within
dpi
suggest
respons
occur
lung
infect
presenc
neutral
antibodi
interestingli
bia
cytokin
induct
also
observ
studi
protein
delta
inulin
use
activ
specif
subset
adjuv
may
critic
ensur
vaccin
efficaci
eosinophil
immunopatholog
upon
infect
overal
protein
induc
igg
respons
fail
induc
protect
antibodi
limit
eosinophil
infiltr
lung
hand
tlr
agonist
success
minim
amount
recombin
protein
requir
vaccin
increas
vaccin
immunogen
reduc
eosinophil
infiltr
lung
challeng
infect
mous
model
prevent
insuffici
immun
even
vaccin
appropri
adjuv
develop
need
find
studi
support
develop
vaccin
infect
also
sever
coronavirus
like
includ
author
declar
conflict
interest
